Paris, France and Camberley, UK – 29 September 2020 – Novacyt, an international specialist in clinical diagnostics, announces that, further to the announcement on 27 July 2020, the Company has
Novacyt S.A. (NCYT.L) Launch of COVID-19 antibody test
Verona Pharma plc (VRP.L) Phase 3 Clinical Trials with Nebulized Ensifentrine
Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD
Novacyt S.A. (NCYT.L) Launch of respiratory test panel
New test differentiates COVID-19 from common winter diseases
Verona Pharma plc (VRP.L) $200 Million in Oversubscribed Private Placement and Subscription
Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on respiratory diseases, announces it has raised approximately $200 million (£159 million*).
Evgen Pharma PLC (EVG.L) SFX-01 to be evaluated in COVID-19 trial
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company, is delighted to announce participation in the recently notified funding initiative for COVID-19 clinical trials by the medical research
Evgen Pharma (EVG.L) Clinical trial that could reduce Covid-19 deaths
The University of Dundee is leading the clinical trial of a new anti-inflammatory drug it is hoped may reduce instances of severe lung damage and death in Covid-19 patients.
Overview facts about hVIVO COVID Clear & FAQ
Open Orphan is a rapidly growing niche CRO pharmaceutical services company which is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical
